Kcng2 | potassium voltage-gated channel, subfamily G, member 2
GeneMGI:3694646
Physiological systems
18 / 24 physiological systems tested
5 Significantly impacted by the knock-out
Homeostasis/metabolism Growth/size/body region Muscle Behavior/neurological Cardiovascular system
13 No significant impact
6 Not tested
Data collections
Gene metrics:5Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
decreased cardiac muscle contractility | 2 supporting datasets | Kcng2em1(IMPC)Bay | homozygote | Early adult | 7.76x10-5 | ||
hyperactivity | 1 supporting dataset | Kcng2em1(IMPC)Bay | homozygote | Early adult | 6.18x10-5 | ||
decreased circulating serum albumin level | 1 supporting dataset | Kcng2em1(IMPC)Bay | homozygote | Early adult | 4.74x10-9 | ||
increased heart weight | 1 supporting dataset | Kcng2em1(IMPC)Bay | homozygote | Early adult | 4.3x10-5 | ||
decreased cardiac stroke volume | 1 supporting dataset | Kcng2em1(IMPC)Bay | homozygote | Early adult | 2.44x10-6 |
| | | | | | | | | |
External links
No external links available for Kcng2.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Kcng2em1(IMPC)Bay | Exon Deletion | | mouse |
Kcng2tm466063(Ifitm2_intron_L1L2_GT2_LF2A_LacZ_BetactP_neo) | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector |